College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, People's Republic of China.
J Colloid Interface Sci. 2012 Nov 15;386(1):428-40. doi: 10.1016/j.jcis.2012.07.076. Epub 2012 Aug 2.
Sulfonated polyethersulfone (SPES) and poly (acrylonitrile-co-acrylic acid-co-vinyl pyrrolidone) (P(AN-AA-VP)), which provided sulfonic acid (-SO(3)H) and carboxylic acid groups (-COOH), respectively, were used to modify polyethersulfone (PES) membrane with a heparin-like surface by blending method. The SPES was prepared by sulfonation of PES using chlorosulfonic acid as the sulfonating agent, while the P(AA-AN-VP) was prepared through a free radical polymerization. The PES and modified PES membranes were prepared by a phase-inversion technique; the modified membranes showed lowered protein (bovine serum albumin, BSA; bovine serum fibrinogen, FBG) adsorption and suppressed platelet adhesion. For the modified membranes, significant decreases in thrombin-antithrombin (TAT) generation, percentage platelets positive for CD62p expression, and the complement activation on C3a and C5a levels were observed compared with those for the pure PES membrane. Due to the similar negatively charged groups as heparin, the modified membranes effectively prolonged the activated partial thromboplastin time (APTT). Furthermore, the modified membranes showed good cytocompatibility. Hepatocytes cultured on the modified materials exhibited improved functional profiles in terms of scanning electron microscope (SEM) observation and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay compared with those on the pure PES membrane. It could be concluded that the modified membranes with sulfonic acid and carboxylic acid groups were endowed with excellent biocompatibility, and the heparin-like surface modification seemed to be a promising approach to improve the biocompatibility of materials.
磺化聚醚砜 (SPES) 和聚 (丙烯腈-丙烯酸-乙烯基吡咯烷酮) (P(AN-AA-VP)) 分别提供磺酸 (-SO(3)H) 和羧酸 (-COOH) 基团,通过共混法被用于对具有肝素样表面的聚醚砜 (PES) 膜进行改性。SPES 通过使用氯磺酸作为磺化剂对 PES 进行磺化来制备,而 P(AA-AN-VP) 通过自由基聚合来制备。PES 和改性 PES 膜通过相转化技术制备;改性膜显示出降低的蛋白质(牛血清白蛋白,BSA;牛血清纤维蛋白原,FBG)吸附和抑制血小板黏附。与纯 PES 膜相比,改性膜观察到血栓酶抗血栓酶 (TAT) 生成、血小板 CD62p 表达阳性的百分比和 C3a 和 C5a 水平上补体激活显著降低。由于具有类似的负电荷基团如肝素,改性膜有效地延长了活化部分凝血活酶时间 (APTT)。此外,改性膜表现出良好的细胞相容性。在扫描电子显微镜 (SEM) 观察和 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐 (MTT) 测定中,培养在改性材料上的肝细胞表现出改善的功能谱,与在纯 PES 膜上相比。可以得出结论,具有磺酸和羧酸基团的改性膜具有优异的生物相容性,肝素样表面改性似乎是改善材料生物相容性的有前途的方法。